Hanna Kunina
Doktorand vid Institutionen för farmaci; Farmakometri
- E-post:
- hanna.kunina@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
Ladda ned kontaktuppgifter för Hanna Kunina vid Institutionen för farmaci; Farmakometri
Publikationer
Senaste publikationer
-
Pharmacometric Modeling of Disease Progression and Biomarker Dynamics in Type 2 Diabetes
2026
-
Ingår i AAPS Journal, 2026
- DOI för Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data
- Ladda ner fulltext (pdf) av Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data
-
Ingår i CPT, s. 606-615, 2025
- DOI för Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality
- Ladda ner fulltext (pdf) av Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality
-
Ingår i CPT, s. 1443-1457, 2022
- DOI för Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation
- Ladda ner fulltext (pdf) av Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation
Alla publikationer
Artiklar i tidskrift
-
Ingår i AAPS Journal, 2026
- DOI för Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data
- Ladda ner fulltext (pdf) av Blood-glucose Profile Evaluation with a Model-based Approach using Continuous Glucose Monitoring Data
-
Ingår i CPT, s. 606-615, 2025
- DOI för Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality
- Ladda ner fulltext (pdf) av Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality
-
Ingår i CPT, s. 1443-1457, 2022
- DOI för Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation
- Ladda ner fulltext (pdf) av Optimization of trial duration to predict long-term HbA1c change with therapy: A pharmacometrics simulation-based evaluation